IRIDEX ROA 2010-2023 | IRIX
Current and historical return on assets (ROA) values for IRIDEX (IRIX) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
| IRIDEX ROA - Return on Assets Historical Data |
| Date |
TTM Net Income |
Total Assets |
Return on Assets |
| 2023-12-31 |
$-0.01B |
$0.03B |
-27.21% |
| 2023-09-30 |
$-0.01B |
$0.04B |
-20.65% |
| 2023-06-30 |
$-0.01B |
$0.04B |
-19.39% |
| 2023-03-31 |
$-0.01B |
$0.04B |
-16.09% |
| 2022-12-31 |
$-0.01B |
$0.04B |
-15.47% |
| 2022-09-30 |
$-0.01B |
$0.05B |
-17.02% |
| 2022-06-30 |
$-0.01B |
$0.05B |
-16.49% |
| 2022-03-31 |
$-0.01B |
$0.05B |
-10.05% |
| 2021-12-31 |
$-0.01B |
$0.05B |
-9.95% |
| 2021-09-30 |
$-0.00B |
$0.05B |
-6.67% |
| 2021-06-30 |
$-0.00B |
$0.05B |
-7.64% |
| 2021-03-31 |
$-0.01B |
$0.05B |
-20.74% |
| 2020-12-31 |
$-0.01B |
$0.03B |
-24.14% |
| 2020-09-30 |
$-0.01B |
$0.03B |
-29.27% |
| 2020-06-30 |
$-0.01B |
$0.03B |
-27.48% |
| 2020-03-31 |
$-0.01B |
$0.03B |
-22.86% |
| 2019-12-31 |
$-0.01B |
$0.04B |
-24.00% |
| 2019-09-30 |
$-0.01B |
$0.04B |
-25.48% |
| 2019-06-30 |
$-0.01B |
$0.04B |
-26.67% |
| 2019-03-31 |
$-0.01B |
$0.04B |
-29.63% |
| 2018-12-31 |
$-0.01B |
$0.04B |
-32.91% |
| 2018-09-30 |
$-0.02B |
$0.04B |
-37.97% |
| 2018-06-30 |
$-0.02B |
$0.04B |
-37.97% |
| 2018-03-31 |
$-0.02B |
$0.04B |
-35.50% |
| 2017-12-31 |
$-0.01B |
$0.04B |
-29.05% |
| 2017-09-30 |
$-0.02B |
$0.04B |
-41.08% |
| 2017-06-30 |
$-0.02B |
$0.05B |
-36.96% |
| 2017-03-31 |
$-0.01B |
$0.05B |
-30.77% |
| 2016-12-31 |
$-0.01B |
$0.05B |
-27.12% |
| 2016-09-30 |
$-0.00B |
$0.04B |
-2.34% |
| 2016-06-30 |
$0.00B |
$0.04B |
0.00% |
| 2016-03-31 |
$-0.00B |
$0.04B |
-2.41% |
| 2015-12-31 |
$-0.00B |
$0.04B |
-2.41% |
| 2015-09-30 |
$0.01B |
$0.04B |
19.28% |
| 2015-06-30 |
$0.01B |
$0.04B |
20.25% |
| 2015-03-31 |
$0.01B |
$0.04B |
24.16% |
| 2014-12-31 |
$0.01B |
$0.04B |
25.71% |
| 2014-09-30 |
$0.00B |
$0.03B |
0.00% |
| 2014-06-30 |
$0.00B |
$0.03B |
3.05% |
| 2014-03-31 |
$0.00B |
$0.03B |
3.08% |
| 2013-12-31 |
$0.00B |
$0.03B |
6.35% |
| 2013-09-30 |
$0.00B |
$0.03B |
6.61% |
| 2013-06-30 |
$0.00B |
$0.03B |
0.00% |
| 2013-03-31 |
$0.00B |
$0.03B |
0.00% |
| 2012-12-31 |
$0.00B |
$0.03B |
3.31% |
| 2012-09-30 |
$0.00B |
$0.03B |
6.45% |
| 2012-06-30 |
$0.00B |
$0.03B |
9.60% |
| 2012-03-31 |
$0.00B |
$0.03B |
12.90% |
| 2011-12-31 |
$0.00B |
$0.03B |
9.84% |
| 2011-09-30 |
$0.00B |
$0.03B |
10.08% |
| 2011-06-30 |
$0.00B |
$0.03B |
13.79% |
| 2011-03-31 |
$0.00B |
$0.03B |
14.16% |
| 2010-12-31 |
$0.00B |
$0.03B |
11.01% |
| 2010-09-30 |
$0.00B |
$0.03B |
11.11% |
| 2010-06-30 |
$0.00B |
$0.03B |
11.21% |
| 2010-03-31 |
$0.00B |
$0.03B |
11.21% |
| 2009-12-31 |
$0.00B |
$0.03B |
10.91% |
| Sector |
Industry |
Market Cap |
Revenue |
| Computer and Technology |
Laser Systems and Components |
$0.048B |
$0.052B |
|
IRIDEX Corporation is the leading worldwide provider of semiconductor-based laser systems used to treat eye diseases in ophthalmology and skin lesions in dermatology. The products are sold in the United States predominantly through a direct sales force and internationally through independent distributors. The company markets the products using three brand names: IRIS Medical to the ophthalmology market, IRIDERM to the dermatology market, and Light Solutions to the research market.
|
